FluoSphera raises CHF 1.2 M

FluoSphera has developed an in vitro platform that combines up to seven human tissue models in a single well to predict drug efficacy and toxicity. The CHF 1.15 million raised, with a Swiss business angel co-leading, will fund commercial development and its AI capabilities.

Announced on
Round
Undisclosed round
Amount
CHF 1.2 M
Location
Geneva
Sector
Biotech & life sciences

Investors

  • Soulmates Ventures lead
  • IndieBio New York

Preparing a similar round?

The diagnostic shows you the instruments and investors that fit your stage.

Start the diagnostic